195 related articles for article (PubMed ID: 31983113)
21. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors.
Choi D; Lim HK; Joh JW; Kim SJ; Kim MJ; Rhim H; Kim YS; Yoo BC; Paik SW; Park CK
Ann Surg Oncol; 2007 Dec; 14(12):3510-8. PubMed ID: 17653800
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effectiveness and safety of ultrasound- and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma.
Wu J; Chen P; Xie YG; Gong NM; Sun LL; Sun CF
Pathol Oncol Res; 2015 Jul; 21(3):637-42. PubMed ID: 25466642
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up.
Huang S; Yu J; Liang P; Yu X; Cheng Z; Han Z; Li Q
Eur J Radiol; 2014 Mar; 83(3):552-8. PubMed ID: 24418287
[TBL] [Abstract][Full Text] [Related]
24. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.
Park MJ; Kim YS; Rhim H; Lim HK; Lee MW; Choi D
J Vasc Interv Radiol; 2011 Jun; 22(6):771-9. PubMed ID: 21616430
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
26. Gallbladder needle decompression during radiofrequency ablation of an adjacent liver tumour.
Fernandes DD; Shyn PB; Silverman SG
Can Assoc Radiol J; 2012 Aug; 63(3 Suppl):S37-40. PubMed ID: 22280789
[TBL] [Abstract][Full Text] [Related]
27. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder.
Meng Y; Jiang B; Yan K; Wang S; Zhang Z; Chen L; Wu W; Yang W
Int J Hyperthermia; 2023; 40(1):2182748. PubMed ID: 36822596
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ultrasound guided versus CT guided radiofrequency ablation on liver function, serum PIVKA-II, AFP levels and recurrence in patients with primary hepatocellular carcinoma.
Yu Z; Li G; Yuan N; Ding W
Am J Transl Res; 2021; 13(6):6881-6888. PubMed ID: 34306439
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach.
Chen MH; Yang W; Yan K; Hou YB; Dai Y; Gao W; Zhang H; Wu W
Abdom Imaging; 2008; 33(4):428-36. PubMed ID: 17639375
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
Hara K; Takeda A; Tsurugai Y; Saigusa Y; Sanuki N; Eriguchi T; Maeda S; Tanaka K; Numata K
Hepatology; 2019 Jun; 69(6):2533-2545. PubMed ID: 30805950
[TBL] [Abstract][Full Text] [Related]
33. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
34. A hepatocellular carcinoma with lymph node metastasis and invasion into the gallbladder: preoperative difficulty ruling out a gallbladder carcinoma.
Ueno N; Kanamaru T; Kawaguchi K; Tanaka K; Inoue K; Idei Y; Yamamoto M
Oncol Rep; 2001; 8(2):331-5. PubMed ID: 11182050
[TBL] [Abstract][Full Text] [Related]
35. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of laparoscopic precise hepatectomy with conventional open hepatectomy in the treatment of primary hepatocellular cancer.
Luo F; Zhou J; Yan W
J BUON; 2019; 24(5):1943-1949. PubMed ID: 31786859
[TBL] [Abstract][Full Text] [Related]
37. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
38. Analysis on the value of soluble intercellular adhesion molecule-1 (sICAM-1), alpha fetoprotein (AFP), and aspartate aminotransferase/platelet ratio index (APRI) in predicting the prognostic survival of patients with primary liver cancer after radiofrequency ablation.
Guo C; Liang H; Yuan W; Qin Y
Ann Palliat Med; 2021 Apr; 10(4):4760-4767. PubMed ID: 33966425
[TBL] [Abstract][Full Text] [Related]
39. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
[TBL] [Abstract][Full Text] [Related]
40. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
